|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.62 AUD | +0.56% |
|
-0.22% | +15.35% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.91B | 3.61B | 3.78B | 3.94B | 3.88B | |||||
Total Revenues | 2.91B | 3.61B | 3.78B | 3.94B | 3.88B | |||||
Cost of Goods Sold, Total | 1.86B | 2.3B | 2.47B | 2.35B | 2.37B | |||||
Gross Profit | 1.05B | 1.31B | 1.31B | 1.59B | 1.5B | |||||
Selling General & Admin Expenses, Total | 390M | 461M | 494M | 602M | 596M | |||||
R&D Expenses | 34.3M | 38M | 39.6M | 47M | 48.5M | |||||
Other Operating Expenses, Total | 424M | 499M | 534M | 649M | 645M | |||||
Operating Income | 630M | 815M | 778M | 939M | 860M | |||||
Interest Expense, Total | -48.5M | -40.3M | -37M | -36.4M | -41M | |||||
Interest And Investment Income | 700K | 1M | 6.3M | 21.1M | 30.7M | |||||
Net Interest Expenses | -47.8M | -39.3M | -30.7M | -15.3M | -10.3M | |||||
Currency Exchange Gains (Loss) | -111M | 7.9M | 21.4M | 1.9M | - | |||||
Other Non Operating Income (Expenses) | -34.5M | -145M | -45.7M | -154M | -140M | |||||
EBT, Excl. Unusual Items | 436M | 638M | 723M | 772M | 710M | |||||
Restructuring Charges | -11.1M | - | - | - | -50.3M | |||||
Merger & Related Restructuring Charges | - | - | - | - | -16.5M | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | -2M | -400K | - | -20.1M | - | |||||
Insurance Settlements | 2M | 5.3M | 100K | 3.1M | 2.1M | |||||
Other Unusual Items | -13.1M | - | - | - | - | |||||
EBT, Incl. Unusual Items | 412M | 643M | 724M | 755M | 645M | |||||
Income Tax Expense | 149M | 184M | 212M | 245M | 221M | |||||
Earnings From Continuing Operations | 263M | 459M | 512M | 510M | 424M | |||||
Net Income to Company | 263M | 459M | 512M | 510M | 424M | |||||
Net Income - (IS) | 263M | 459M | 512M | 510M | 424M | |||||
Net Income to Common Incl Extra Items | 263M | 459M | 512M | 510M | 424M | |||||
Net Income to Common Excl. Extra Items | 263M | 459M | 512M | 510M | 424M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.59 | 1.03 | 1.15 | 1.16 | 0.98 | |||||
Basic EPS - Continuing Operations | 0.59 | 1.03 | 1.15 | 1.16 | 0.98 | |||||
Basic Weighted Average Shares Outstanding | 444M | 445M | 445M | 438M | 431M | |||||
Net EPS - Diluted | 0.59 | 1.03 | 1.15 | 1.16 | 0.98 | |||||
Diluted EPS - Continuing Operations | 0.59 | 1.03 | 1.15 | 1.16 | 0.98 | |||||
Diluted Weighted Average Shares Outstanding | 445M | 446M | 446M | 440M | 432M | |||||
Normalized Basic EPS | 0.61 | 0.9 | 1.02 | 1.1 | 1.03 | |||||
Normalized Diluted EPS | 0.61 | 0.89 | 1.01 | 1.1 | 1.03 | |||||
Dividend Per Share | - | 0.7 | - | - | - | |||||
Payout Ratio | - | 105.42 | 25.31 | - | - | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 765M | 976M | 951M | 1.12B | 1.08B | |||||
EBITA | 632M | 818M | 782M | 944M | 865M | |||||
EBIT | 630M | 815M | 778M | 939M | 860M | |||||
EBITDAR | 784M | 1B | 974M | 1.15B | 1.11B | |||||
Effective Tax Rate - (Ratio) | 36.21 | 28.61 | 29.23 | 32.41 | 34.3 | |||||
Current Domestic Taxes | 38.5M | 44.4M | 42.9M | 38.7M | 30M | |||||
Current Foreign Taxes | -8.6M | 53.9M | 81.4M | 133M | 90M | |||||
Total Current Taxes | 29.9M | 98.3M | 124M | 172M | 120M | |||||
Deferred Domestic Taxes | 1.4M | 9.4M | 11.8M | 17.3M | 16.3M | |||||
Deferred Foreign Taxes | 118M | 76.3M | 75.4M | 55.6M | 85.1M | |||||
Total Deferred Taxes | 119M | 85.7M | 87.2M | 72.9M | 101M | |||||
Normalized Net Income | 273M | 399M | 452M | 482M | 444M | |||||
Interest Capitalized | 9.5M | 1.9M | 8.5M | 19.5M | 21M | |||||
Interest on Long-Term Debt | 100K | 100K | 200K | 200K | 200K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | 53.7M | 83.1M | 111M | 99.4M | |||||
Research And Development Expense From Footnotes | 37.2M | 42.1M | 41.8M | 47M | 48.5M | |||||
Net Rental Expense, Total | 19.1M | 23.3M | 23.4M | 26.9M | 31.7M | |||||
Imputed Operating Lease Interest Expense | 7.59M | 8.38M | 8.13M | 10.26M | 13.04M | |||||
Imputed Operating Lease Depreciation | 11.51M | 14.92M | 15.27M | 16.64M | 18.66M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 39.7M | 12.2M | 18.4M | 45.5M | 25.7M | |||||
Total Stock-Based Compensation | 39.7M | 12.2M | 18.4M | 45.5M | 25.7M |
- Stock Market
- Equities
- JHX Stock
- Financials James Hardie Industries plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















